Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study
- 30 November 1986
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 22 (11), 1337-1345
- https://doi.org/10.1016/0277-5379(86)90142-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984
- A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.Journal of Clinical Oncology, 1984
- Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?Journal of Clinical Oncology, 1984
- Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 1983
- Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcomaCancer, 1981
- Adjuvant multiple drug chemotherapy for osteosarcoma of the extremityCancer, 1977
- Adjuvant chemotherapy in primary treatment of osteogenic sarcoma.A southwest oncology group studyCancer, 1975
- Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcomaCancer, 1975
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- Recent advances in the chemotherapy of metastatic osteogenic sarcomaCancer, 1972